MedTrace Logo

Teleneurorehabilitation for the Continuity of Care Post-stroke: a Multicentric Pilot Study

NCT05703906 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2023-01-30

No results posted yet for this study

Summary

The main aim of this longitudinal, pilot study is to evaluate the feasibility of a multi-domain (i.e., motor, language and cognitive domains) telerehabilitation system using the Virtual Reality Rehabilitation System (VRRS, Khymeia) in patients with stroke. Furthermore, data on patients' needs and clinical data will be collected before and after treatment and then analyzed.

Conditions

Interventions

BEHAVIORAL

Telerehabilitation - VRRS Khymeia

Participants will receive an individualized, multidomain exercise program set up by the therapist, based on their needs. The intervention applied will consist of 20 sessions of motor, language and/or cognitive training distributed in five sessions for week, each lasting 1 hour. Remotely, the therapist will supervise the participant's exercise program.

Sponsors & Collaborators

  • IRCCS Centro Neurolesi Bonino Pulejo

    collaborator OTHER

  • Fondazione Don Carlo Gnocchi Onlus

    collaborator OTHER

  • Fondazione Mondino

    collaborator OTHER

  • IRCCS San Raffaele Roma

    collaborator OTHER

  • Istituto Clinico Humanitas

    collaborator OTHER

  • IRCCS San Camillo, Venezia, Italy

    lead OTHER

Principal Investigators

  • Luisa Cacciante, MSc · IRCCS San Camillo Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-16
Primary Completion
2021-11-30
Completion
2021-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05703906 on ClinicalTrials.gov